Haruka Wada
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Mimicking the night shift: Hypothalamic-pituitary-adrenal (HPA) axis regulation, energy homeostasis, and oxidative stress in a model diurnal songbird.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025
Amelioration of liver fibrosis with autologous macrophages induced by IL-34-based condition.
Journal: Inflammation and regeneration
Published: August 26, 2024
Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition.
Journal: Journal for immunotherapy of cancer
Published: October 06, 2023
A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin.
Journal: Oncoimmunology
Published: August 03, 2023
Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells.
Journal: Oncoimmunology
Published: May 26, 2023
Heat-induced maternal effects shape avian eggshell traits and embryo development and phenotype at high incubation temperatures.
Journal: Ecology and evolution
Published: March 31, 2023
Induced pluripotent stem cell-derived hematopoietic stem and progenitor cells induce mixed chimerism and donor-specific allograft tolerance.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: November 09, 2022
Induction of allograft tolerance by adoptive transfer of donor B cells: an immune regulatory strategy for transplantation using MHC-matched iPS cells.
Journal: International immunology
Published: September 13, 2022
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor.
Journal: Journal of gynecologic oncology
Published: June 23, 2022
Erratum: Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade.
Journal: iScience
Published: January 14, 2022
Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: January 12, 2022
Last Updated: 09/26/2026